AZD5305

CAS No. 2589531-76-8

AZD5305( —— )

Catalog No. M24160 CAS No. 2589531-76-8

AZD5305 is a potent, selective and oral active PARP inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 222 In Stock
10MG 357 In Stock
25MG 597 In Stock
50MG 851 In Stock
100MG 1152 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AZD5305
  • Note
    Research use only, not for human use.
  • Brief Description
    AZD5305 is a potent, selective and oral active PARP inhibitor.
  • Description
    AZD5305 is a potent, selective and oral active PARP inhibitor.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Female Han Wistar rats with BRCAm xenograft and PDX models (12-13 weeks of age)Dosage:0.01, 0.03, 0.1, and 0.3 mg/kg Administration:Oral administration; daily, for 35 days Result:Had antitumor efficacy in a dose-dependent manner.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PARP
  • Recptor
    PARP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2589531-76-8
  • Formula Weight
    406.48
  • Molecular Formula
    C22H26N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:41.67 mg/mL (102.51 mM; Need ultrasonic)
  • SMILES
    O=C(C1=NC=C(N2CCN(CC3=CC(N4)=C(N=C3)C=C(CC)C4=O)CC2)C=C1)NC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Gemcabene calcium

    Gemcabene (PD-72953, PD72953) is a first-in-class lipid-lowering agent and activator of PARP.

  • TIQ-A

    TIQ-A is a PARP1 inhibitor which involved in DNA single-strand break repair via the base excision repair pathway. PARP1 is triggered by DNA damage and its excessive activation has been proposed as a causative factor in many pathological conditions including ischemia and reperfusion injury, asthma-related inflammation, and atherogenesis.

  • Talazoparib tosylate

    Talazoparib tosylate is a novel and potent PARP1/2 (n IC50: 0.57 nM for PARP1).